Center for Functional Onco-Imaging, University of California
Irvine, California, 92697, United States
NCT Number: NCT00610558
This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Irvine, California, 92697, United States
We would like to continue analyzing the structural and metabolic differences between two epilepsy groups (JME and FLE) and the control to understand the imaging presentations of epilepsy patients
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Controls (20 Subjects):
Inclusion criteria
Exclusion criteria
Juvenile Myoclonic Epilepsy (JME; 20 Subjects):
Inclusion criteria
Exclusion criteria
Frontal Lobe Epilepsy (FLE; 20 Subjects):
Inclusion criteria
Exclusion criteria
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI
Time frame: During Imaging Session
We will analyze the structural and metabolic differences between two epilepsy groups (JME and FLE) and understand the imaging presentations of epilepsy patients. We will process imaging requisition for Arm 1 and Arm 2 patients and the controls to examine if any differences in their brain image. The hypothesis is the functional connectivity between brainstem structures and cortical/subcortical regions may reflect in their imaging data. We would like to know if these imaging factors are related to epilepsy (JME and FLE) patients.
University of California, Irvine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT06546410
Brain Diseases, Central Nervous System Diseases
Liverpool, United Kingdom
View Trial DetailsNCT07689084
Brain Diseases, Central Nervous System Diseases
Marburg, Hesse, Germany
View Trial DetailsNCT07689617
Brain Diseases, Central Nervous System Diseases
Elâzığ, Turkey (Türkiye)
View Trial Details